Charles Schwab Investment Management Inc. Purchases 84,904 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX)
Charles Schwab Investment Management Inc. lifted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 7.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,269,513 shares of the biopharmaceutical company’s stock after buying an additional 84,904 shares during the quarter. Charles Schwab […]
